New England Peptide Adds Former Rival to Growing Team; Global Peptide Founder Phipps Named West Coast Business Development Chief

Share Article

New England Peptide Names former rival and Global Peptide founder, John Phipps as West Coast Business Development Chief.

John built GPS into one of the top peptide manufacturers in the Western United States and now will bring his significant experience and network to grow NEP's market share in that region.

New England Peptide, LLC, (NEP) has named John Phipps, a leading peptide chemist and entrepreneur, to the new position of western region business development manager. In 2001, Phipps founded Global Peptide Services, a Colorado-based custom peptide synthesis company that produced molecules for biological research and development.

"John has always been an innovative and respected leader in the peptide community and we're very pleased he's joining NEP's growing team," said NEP CEO Dave Robinson. "John built GPS into one of the top peptide manufacturers in the Western United States and now will bring his significant experience and network to grow NEP's market share in that region."

Phipps served as chief executive of GPS until it was purchased by a competitor in 2007. Most recently, Phipps was President of Biolink Solutions, which supplies customized bio-conjugation services to life sciences firms and hospitals. Robinson noted that Phipps has an impressive track record of commitment to top-notch customer service throughout his career.

In his new role at NEP, Phipps will apply his significant peptide experience to develop custom solutions for new customers. Phipps said he was pleased to be part of a global peptide leader that shares his business philosophy.

"I have always been very impressed with NEP and feel that the company's mission and culture fits very well with my own goals and values," said Phipps. "In fact, I used NEP as model for building Global Peptide Services."

Phipps is one of many talented peptide professionals NEP has brought aboard in recent months. In December, NEP named award winning peptide research expert Dr. Robert Hammer as its vice president of chemical development. Hammer and new SAB members Dr. Robert Hodges, are leading NEP's transition to the use of alternative solvents amid a global shortage of acetonitrile.

Dr. Vincent Bille, Dr. Tomi Sawyer, Dr. Victor Hruby are the other members of the SAB, which was formed in October. Another member of the SAB, Dr. Ved Srivastava, left the board in February to become NEP's vice president for research production.

About New England Peptide (http://www.newenglandpeptide.com)
New England Peptide, founded in 1998, designs and produces custom peptides and polyclonal antibodies for drug and vaccine discovery organizations worldwide. Headquartered in the Boston metro area in Gardner, Mass., the company's chemists and immunological experts specialize in delivering a full range of services for biotech and pharmaceutical applications.

Peptides are small proteins that play key roles in biochemical regulation of all life systems, helping to fight diseases as diverse as cancer, diabetes, obesity and HIV/AIDS. Peptides' inherent low toxicity and high potency, coupled with improved drug delivery methods and enhanced manufacturing capabilities, are fueling a surge in research and clinical use. All segments of the peptide market - from therapeutics and vaccines to diagnostics and cosmetics - are thriving.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cort Boulanger
Visit website